治疗性ERCP在胆胰疾病中的应用价值  

The role of therapeutic ERCP in the treatment of biliary-pancreatic diseases with a report of 2165 cases

作　　者：麻树人[1] 邵晓冬[1] 张宁[1] 潘汝明[1] 杨琳[1] 宫照杰[1] 常丽娅[1] 赵云峰[1] 高飞[1] 

机构地区：[1]沈阳军区总医院消化内镜中心,110016

出　　处：《中华消化内镜杂志》2006年第1期31-34,共4页Chinese Journal of Digestive Endoscopy

摘　　要：目的探讨治疗性ERCP在胆胰系统疾病中的治疗价值。方法对1995年7月至2005年11月的2165例经ERCP治疗的病例资料进行回顾性分析,以评价治疗性ERCP在各种胆胰疾病中的应用价值。结果治疗性ERCP成功率98·7%,治疗病例中胆管结石最多,占51·6%,其次为恶性胆道梗阻,占18·6%,乳头良性狭窄占9·4%,急性胆源性胰腺炎占6·7%,急性梗阻性化脓性胆管炎占6·3%,医源性胆道损伤占3·2%,慢性胰腺炎占3·0%,胆道蛔虫占0·6%,其他0·6%。并发症发生率1·2%,其中穿孔死亡1例。结论治疗性ERCP对多种胆胰疾病疗效确实,是一种安全有效的胆胰疾病治疗手段。Objective To evaluate the role of therapeutic ERCP in the treatment of biliary-pancreatic diseases. Methods Two thousand one hundred and sixty five cases, which were treated with therapeutic ERCP from July 1995 to November 2005, were retrospectively reviewed to assess its role in the treatment of various biliary-pancreatic diseases. Results The success rate of therapeutic ERCP is 98.7% that was used to treat bile duct stone （51.6%）, malignant biliary obstruction （18.6%）, benign papillary stricture （9.4%）, acute biliary pancreatitis （6. 7% ）, acute obstructive suppurative cholangitis （6. 5% ）, iatrogenic biliary injury （ 3.2% ）, chronic pancreatitis （ 3.0% ）, biliary tract ascariasis （ 0. 6% ） and others （0. 6% ）. Complication incidence was 1. 2% and a case died from perforation. Conclusion Therapeutic ERCP is an effective and safe treatment for various biliary-pancreatic diseases.

关 键 词：胆胰管造影术 内镜逆行 治疗 胆道疾病 胰腺疾病 

分 类 号：R57[医药卫生—消化系统]